Main page content

Displaying results 1 - 7 of 7
Publication ID: PEP23-02-01-002
Published:

This Advisory outlines how healthcare providers (i.e., obstetrician-gynecologists [OB-GYNs], primary care physicians, and other professionals who treat pregnant people) can take an active role in supporting the health of pregnant individuals who have OUD and their babies.

Publication ID: PEP23-02-00-002
Published:

The third supplemental to SAMHSA’s Clinical Guidance for Treating Pregnant and Parenting Women with Opioid Use Disorder and Their Infants publication. A compendium of resources for professionals who work with parents involved with child welfare.

Publication ID: PEP23-02-00-003
Published:

The second supplemental to SAMHSA’s Clinical Guidance for Treating Pregnant and Parenting Women with Opioid Use Disorder and Their Infants publication. This document contains information for pregnant people with a substance use disorder and professionals who provide services for them.

Publication ID: PEP23-02-00-004
Published:

This document accompanies the Clinical Guidance for Treating Pregnant and Parenting Women with Opioid Use Disorder and Their Infants publication. It offers information about child welfare systems and what the health care provider's role is in developing a Plan of Safe Care.

Publication ID: SMA18-5054
Published:

This Clinical Guide provides comprehensive, national guidance for optimal management of pregnant and parenting women with opioid use disorder and their infants. The Clinical Guide helps healthcare professionals and patients determine the most clinically appropriate action for a particular situation and informs individualized treatment decisions.

Publication ID: SMA15-4426
Published:

This guide assists providers in offering treatment to women living with substance use disorders. It reviews gender-specific research and best practices, such as common patterns of initial use and specific treatment issues and strategies.

Publication ID: SMA13-4789
Published:

This quick guide helps clinicians address the specific needs of women living with substance use disorders. It reviews gender-specific research and best practices—such as common patterns of misuse—and specific screening and treatment strategies.